FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

1267301000168103: Dexmedetomidine (Alphapharm) (dexmedetomidine 200 microgram / 2 mL) injection, 25 x 2 mL vials (containered trade product pack)


Status: current, Defined. Date: 31-Mar 2019. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3247901000168115 Dexmedetomidine (Alphapharm) (dexmedetomidine 200 microgram / 2 mL) injection, 25 x 2 mL vials (containered trade product pack) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3247911000168117 Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials Is a Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials true Inferred relationship Some
Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials Is a containered trade product pack true Inferred relationship Some
Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials has TPUU Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 2 mL vial true Inferred relationship Some 1
Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials has container type vial true Inferred relationship Some
Dexmedetomidine (Alphapharm) 200 microgram/2 mL injection, 25 x 2 mL vials has TP Dexmedetomidine (Alphapharm) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group

Reference Sets

Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)

Containered trade product pack reference set

Back to Start